Register entry

Idorsia Pharmaceuticals Ltd

Data as of · How to read this entry

Registered sites
0
Active NDC listings
3
Live patents
12
Exclusivities
2
Countries
0
Catalogue

Drug listings by form and route

3

3 active NDC listings: 3 human prescription drug. By marketing category: NDA 3.

Dosage formNDCs
tablet, film coated3
RouteNDCs
oral3
Labeller name on the listingNDCs
idorsia pharmaceuticals ltd3
Exclusivity

Patents and exclusivities

12
PatentProductCoversExpiry
8324232TRYVIOaprocitentansubstance, productSept 2029
9732075QUVIVIQdaridorexant hydrochloridesubstance, productJun 2033
10023560QUVIVIQdaridorexant hydrochlorideuseDec 2034
9790208QUVIVIQdaridorexant hydrochloridesubstance, productDec 2034
11174247TRYVIOaprocitentanuseNov 2037
10919881TRYVIOaprocitentansubstance, productFeb 2038
12297189TRYVIOaprocitentanproductFeb 2038
11787782TRYVIOaprocitentanuseMar 2038
11680058TRYVIOaprocitentanuseJul 2038
ProductExclusivityUntil
QUVIVIQDARIDOREXANT HYDROCHLORIDEM-200 MiscellaneousSept 2027
TRYVIOAPROCITENTANNCE New chemical entityMar 2029
Catalogue

Marketed products

3
BrandGeneric nameForm / routeNDC
QUVIVIQDaridorexanttablet, film coated, oral80491-7825NDA
QUVIVIQDaridorexanttablet, film coated, oral80491-7850NDA
TRYVIOAprocitentantablet, film coated, oral80491-8012NDA
Enquiry

Common questions

Is Idorsia Pharmaceuticals Ltd FDA approved?
Idorsia Pharmaceuticals Ltd holds no registered establishment of its own; 3 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
What drugs does Idorsia Pharmaceuticals Ltd make?
3 products are listed under Idorsia Pharmaceuticals Ltd in the openFDA NDC Directory, most often as tablet, film coated. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.